FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3964987 · Received July 29, 2014

Report

Report Number
2124215-2014-14643
Event Type
Injury
Date Received
July 29, 2014
Date of Event
May 17, 2014
Report Date
April 20, 2017
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

AT THIS TIME, THE LEAD HAS NOT BEEN RETURNED. IF THE LEAD IS RETURNED, ANALYSIS WILL BE PERFORMED AND THIS REPORT WOULD BE UPDATED AT THAT TIME.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED WHICH NOTED THAT THIS RV LEAD WAS EXPLANTED DUE TO CHRONICALLY LOW PACING IMPEDANCE MEASUREMENTS OF LESS THAN 200 OHMS. THE PATIENT HAD A RECENT ATRIOVENTRICULAR (AV) NODAL ABLATION, WHICH CAUSED THE PATIENT TO BECOME PACEMAKER DEPENDENT. THE LEAD HAD BEEN PACING AND SENSING WELL, AND NORMAL CAPTURE WAS NOTED. A SURGICAL REVISION WAS PERFORMED AND THE LEAD WAS EXPLANTED AND REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND RIGHT VENTRICULAR (RV) LEAD EXHIBITED LOW, OUT OF RANGE PACING LEAD IMPEDANCE MEASUREMENTS LESS THAN 200 OHMS DETECTED VIA THE PATIENT REMOTE MONITORING SYSTEM. IMPEDANCE TREND REVEALED THAT AN OUT OF RANGE MEASUREMENT WAS JUST RECENTLY DETECTED AS PACING IMPEDANCE HAS ALWAYS BEEN IN MID-200 OHMS. FURTHER, ARRHYTHMIA LOGBOOK SHOWED AN EPISODE WITH SOME OVERSENSED NOISE. SUBSEQUENTLY, THE PATIENT WAS BROUGHT IN FOR FURTHER EVALUATION AND NORMAL PACING AND SENSING FUNCTION WITH IMPEDANCE IN AN ACCEPTABLE RANGE WAS OBSERVED. MOREOVER, NOISE COULD NOT BE RECREATED WITH ISOMETRICS. THE PHYSICIAN OPTED TO CLOSELY MONITOR THE PATIENT AND SCHEDULED FOLLOW-UP IN A MONTH. AT THIS TIME, THE SYSTEM REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
441511 ENDOTAK RELIANCE NVY CPI - DEL CARIBE 0293

Patients

Seq Age Sex Outcome Treatment
1 59 YR Hospitalization| L| R 6947| 5076| 0293| 4046| 4593| N161| 6949| MISMATCH| N160| N119| 4194| 4471